BioCentury
ARTICLE | Finance

COVID stocks spike as market volatility continues

Valuation swings for five biotechs at the center of the COVID-19 race

March 20, 2020 11:33 PM UTC
Updated on Mar 21, 2020 at 12:56 AM UTC

As the broader markets continue to tumble amidst the COVID-19 pandemic, several biotechs at the center of the race to develop countermasures have seen their valuations swing wildly since the crisis began to unfold in January.

Five companies in particular have seen some of the largest peaks and valleys as investors -- in particular retail investors -- frantically trade on seemingly every piece of COVID-19 news...